Country: Global

A Call for Modern Patient-Centered Type 1 Diabetes Treatment Guidelines

15 May 2026, 1:13 p.m. in Content Type: News & Statements, Country: Global, Insulin Access: Modern Insulins by T1International

T1International is urging the World Health Organization to include insulin analogues and insulin pens in its Type 1 Diabetes Treatment Guidelines to promote safer, more flexible, and more equitable diabetes care worldwide. The statement argues that these modern treatments improve quality of life, dosing accuracy, dignity, and health outcomes, while highlighting the inequities faced by people in low- and middle-income countries who often lack access to them. It also emphasizes the importance of including the lived experiences of people with diabetes in global healthcare policymaking to ensure treatment standards reflect both clinical evidence and real-world needs. Read more

World Diabetes Day 2025: Advocates stand together for Access, Affordability, and Action

16 Nov 2025, 7:39 p.m. in Action & Workshop, Country: Democratic Republic of Congo, Country: Egypt, Country: France, Country: Global, Country: Nigeria, Country: Pakistan, Country: Sierra Leone, Country: South Africa, Country: United States, Insulin Access: Price Caps, Taking on Monopoly Power: Public Pharma, The Right to Full Care: Combatting Discrimination with Education, The Right to Full Care: Glucose Self-Monitoring Supplies, The Right to Full Care: Other Essential Medicine Access & Universal Health Coverage by T1International

On November 14th, 2025, World Diabetes Day, #insulin4all advocates across the globe came together to make a demand: that they be able to access and afford their life-sustaining medications. Recent data showed that 1 in 3 people around the world rationed their insulin due to cost in 2024. At T1International, we know that #insulin4all is a reasonable and dignified demand– and yet, we are still too far from achieving a reality where everyone, no matter where they live, has access to the medicine and supplies they need to survive and flourish. Read more

World Health Organization Approves Rapid-Acting Insulin Analogues to the 24th EML

5 Sep 2025, 2:56 p.m. in Content Type: News & Statements, Country: Global, Insulin Access: Modern Insulins by T1International

Global Diabetes Advocates Urge Novo Nordisk’s New CEO to Prioritize People Over Profits

7 Aug 2025, 8:27 p.m. in Content Type: News & Statements, Country: Global, Insulin Access: Price Caps by T1International

T1International at the United Nations Multi-stakeholder hearing on NCDs and Mental Health

5 May 2025, 7:52 p.m. in Content Type: News & Statements, Country: Global, Organizational Updates by T1International

On May 2, 2025, #insulin4all advocates, including T1International’s Executive Director Shaina Kasper, participated in a high-level United Nations hearing to shape the agenda for the upcoming Political Declaration on noncommunicable diseases. In remarks, Kasper called on UN member states to urgently address insulin affordability, support public manufacturing, and center patients in global diabetes policy decisions. Emphasizing that the insulin crisis is far from over, she highlighted patient stories from around the world and urged bold action to ensure equitable access to lifesaving diabetes care. Read more

Progress on Insulin Access: Adding Rapid-Acting Insulin Analogues to the Essential Medicines List

9 Apr 2025, 10:04 p.m. in Content Type: Advocacy Stories, Country: Global, Insulin Access: Modern Insulins by T1International

Open letter to WHO calling for urgent action on meaningful patient engagement

2 May 2024, 6:41 p.m. in Content Type: News & Statements, Country: Global, The Right to Full Care: Combatting Discrimination with Education by T1International

We are writing to propose WHO action items aimed at addressing meaningful engagement with people living with diabetes in the global coverage targets for diabetes. Read more

Advocating To Define “Affordable” for People With Diabetes

10 Nov 2023, 9:47 a.m. in Country: Global, Insulin Access: Price Caps, Organizational Updates, Research by T1International

To kick off Diabetes Awareness Month, the Global Diabetes compact held a two-day meeting where T1International and 35 other organisations in over 25 countries presented the goal of the Fight for Five campaign. We showed the depth and breadth of support for this campaign not only through stories of patients most impacted by lack of affordable and accessible insulin in their home countries, but also by the number of organisations that support a better world for people with diabetes. Read more

Three Reasons Why is Insulin STILL So Expensive

29 Aug 2023, 4:49 p.m. in Contains: Resource, Country: Global, Insulin Access: Alec's Law, Insulin Access: Kevin's Law, Insulin Access: Modern Insulins, Insulin Access: Price Caps, Taking on Monopoly Power: Patent Reform, Taking on Monopoly Power: Public Pharma by Shaina Kasper

Over the past few months, many insulin manufacturers and other entities have announced that they will be lowering the price of insulin in the United States. So, why is insulin still so expensive?
We recently released our Policy Playbook that goes through all of the details and gives advocates the information to push for change locally and nationally. Why insulin is so expensive can be boiled down to three main points. Read more